Cargando…
COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination()
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI).
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482697/ https://www.ncbi.nlm.nih.gov/pubmed/34593364 http://dx.doi.org/10.1016/j.rceng.2021.05.002 |
| _version_ | 1784576963417997312 |
|---|---|
| author | Aomar-Millán, I.F. Martínez de Victoria-Carazo, J. Peregrina-Rivas, J.A. Villegas-Rodríguez, I. |
| author_facet | Aomar-Millán, I.F. Martínez de Victoria-Carazo, J. Peregrina-Rivas, J.A. Villegas-Rodríguez, I. |
| author_sort | Aomar-Millán, I.F. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8482697 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-84826972021-09-30 COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() Aomar-Millán, I.F. Martínez de Victoria-Carazo, J. Peregrina-Rivas, J.A. Villegas-Rodríguez, I. Rev Clin Esp (Barc) Correspondence Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). 2021-11 2021-09-27 /pmc/articles/PMC8482697/ /pubmed/34593364 http://dx.doi.org/10.1016/j.rceng.2021.05.002 Text en © 2021 Elsevier España, S.L.U. and Sociedad Española de Medicina Interna (SEMI). All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Correspondence Aomar-Millán, I.F. Martínez de Victoria-Carazo, J. Peregrina-Rivas, J.A. Villegas-Rodríguez, I. COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title | COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title_full | COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title_fullStr | COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title_full_unstemmed | COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title_short | COVID-19, Guillain-Barré syndrome, and the vaccine. A dangerous combination() |
| title_sort | covid-19, guillain-barré syndrome, and the vaccine. a dangerous combination() |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8482697/ https://www.ncbi.nlm.nih.gov/pubmed/34593364 http://dx.doi.org/10.1016/j.rceng.2021.05.002 |
| work_keys_str_mv | AT aomarmillanif covid19guillainbarresyndromeandthevaccineadangerouscombination AT martinezdevictoriacarazoj covid19guillainbarresyndromeandthevaccineadangerouscombination AT peregrinarivasja covid19guillainbarresyndromeandthevaccineadangerouscombination AT villegasrodriguezi covid19guillainbarresyndromeandthevaccineadangerouscombination |